GelTech Solutions (GLTC) 10-Q 12 Feb 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Dec. 31, 2013	Feb. 11, 2014
Document and Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Dec-13	'
Entity Registrant Name	'GelTech Solutions, Inc.	'
Entity Central Index Key	'0001403676	'
Current Fiscal Year End Date	'--06-30	'
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	37,413,095

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Jun. 30, 2013
Current assets	'	'
Cash and cash equivalents	$141,108	$90,275
Accounts receivable trade, net	25,022	37,277
Inventories	863,144	588,703
Prepaid expenses and other current assets	146,886	66,756
Total current assets	1,176,160	783,011
Furniture, fixtures, and equipment, net	189,165	158,184
Deposits	26,886	26,886
Total assets	1,392,211	968,081
Current liabilities	'	'
Accounts payable	234,486	265,122
Accrued expenses	301,376	176,734
Litigation accrual	505,000	505,000
Accrual for severance agreement	17,596	102,056
Convertible notes - related parties, net of discount	'	79,261
Convertible notes - third parties, net of discount	'	192,163
Insurance premium finance contract	65,268	11,796
Deferred revenue	57,019	7,019
Total current liabilities	1,180,745	1,339,151
Convertible notes - related party, net of discounts	2,091,779	1,899,316
Total liabilities	3,272,524	3,238,467
Commitments and contingencies (Note 5)	'	'
Stockholders' equity (deficit)	'	'
Preferred stock: $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	'	'
Common stock: $0.001 par value; 50,000,000 shares authorized; 35,996,039 and 33,084,671 shares issued and outstanding as of December 31, 2013 and June 30, 2013, respectively.	35,996	33,084
Additional paid in capital	30,069,571	25,718,163
Accumulated deficit	-31,985,880	-28,021,633
Total stockholders' equity (deficit)	-1,880,313	-2,270,386
Total liabilities and stockholders' equity (deficit)	$1,392,211	$968,081

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Jun. 30, 2013
CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]	'	'
Preferred stock, par value per share	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$0.00	$0.00
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	35,996,039	33,084,671
Common stock, shares outstanding	35,996,039	33,084,671

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]	'	'	'	'
Sales	$65,034	$37,453	$595,846	$121,903
Cost of goods sold	34,340	13,499	262,073	49,578
Gross profit	30,694	23,954	333,773	72,325
Operating expenses:	'	'	'	'
Selling, general and administrative expenses	1,894,228	1,526,616	3,926,272	3,076,098
Research and development	50,663	6,423	137,831	23,731
Total operating expenses	1,944,891	1,533,039	4,064,103	3,099,829
Loss from operations	-1,914,197	-1,509,085	-3,730,330	-3,027,504
Other income (expense)	'	'	'	'
Loss on settlement	-11,413	'	-11,413	'
Other income	'	200,000	17,000	200,000
Interest income	17	514	260	565
Loss on repricing warrants	'	'	'	-70,491
Interest expense	-127,392	-97,226	-239,764	-314,054
Total other income (expense)	-138,788	103,288	-233,917	-183,980
Net loss	($2,052,985)	($1,405,797)	($3,964,247)	($3,211,484)
Net loss per common share - basic and diluted	($0.06)	($0.05)	($0.12)	($0.12)
Weighted average shares outstanding - basic and diluted	35,147,692	28,877,700	34,358,586	27,387,133

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities	'	'
Net loss	($3,964,247)	($3,211,484)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation	26,112	25,346
Allowance for bad debt	5,801	'
Amortization of debt discounts	118,771	274,426
Vesting of restricted stock units	'	90,000
Stock option employee compensation expense	1,235,650	990,559
Cost of repricing warrants to induce exercise	'	70,491
Loss on stock issued for interest	4,440	'
Payment by insurance company of prior period accrued litigation expense	'	-200,000
Changes in assets and liabilities:	'	'
Accounts receivable	6,454	11,444
Inventories	-274,441	-29,665
Prepaid expenses and other current assets	12,716	21,603
Accounts payable	-30,636	-32,669
Deferred revenue	50,000	'
Accrued expenses	124,642	-4,542
Accrual for termination and release agreement	-84,460	'
Net cash used in operating activities	-2,769,198	-1,994,491
Cash flows from Investing Activities	'	'
Purchases of equipment	-57,093	-3,285
Net cash (used in) investing activities	-57,093	-3,285
Cash flows from Financing Activities	'	'
Proceeds from sale of stock through private placements	775,000	128,000
Proceeds from the sale of stock and warrants through private placements	730,000	'
Proceeds from sale of stock under stock purchase agreement	570,000	810,003
Proceeds from exercise of warrants	25,000	910,000
Proceeds from exercise of stock options	18,200	'
Payments on related party notes	'	-59,839
Proceeds from convertible notes with third parties	'	175,000
Proceeds from convertible notes with related parties	1,000,000	250,000
Repayment on convertible notes with third parties	-115,822	'
Repayments on convertible notes with related parties	-85,880	'
Payments on Insurance Finance Contract	-39,374	-19,033
Net cash provided by financing activities	2,877,124	2,194,131
Net increase in cash and cash equivalents	50,833	196,355
Cash and cash equivalents - beginning	90,275	84,194
Cash and cash equivalents - ending	141,108	280,549
Supplemental Disclosure of Cash Flow Information:	'	'
Cash paid for interest	1,219	296
Cash paid for income taxes	'	'
Supplementary Disclosure of Non-cash Investing and Financing Activities:	'	'
Financing of prepaid insurance contracts	92,846	47,471
Beneficial conversion feature of convertible notes	311,949	190,280
Loan discount from warrants	601,949	'
Stock issued for interest	4,440	'
Conversion of notes for common stock	$82,132	$332,996

Organization_and_Basis_of_Pres

Organization and Basis of Presentation	6 Months Ended
	Dec. 31, 2013
Organization and Basis of Presentation [Abstract]	'
Organization and Basis of Presentation	'
	NOTE 1 - Organization and Basis of Presentation
	Organization
	GelTech Solutions, Inc., or GelTech, markets the following products: (1) FireIce®, a water enhancing powder that can be utilized both as a fire suppressant in urban firefighting, including underground utility fires, and in wildland firefighting and as a medium-term fire retardant to protect wildlands, structures and firefighters; (2) Emergency Manhole FireIce Delivery System, or EMFIDS, an innovative system designed to deliver FireIce® into a manhole in the event of a fire; (3) FireIce® Home Defense Unit, a system for applying FireIce® to structures to protect them from wildfires; (4) Soil2O® "Dust Control", our new application which is used for dust mitigation in the aggregate, road construction, mining, as well as, other industries that deal with daily dust control issues; and (5) Soil2O®, a product which reduces the use of water and is primarily marketed to golf courses, commercial landscapers and the agriculture market.  Our financial statements have been prepared on a going concern basis, and we need to generate sufficient material revenues to support the ongoing business of GelTech.
	The corporate office is located in Jupiter, Florida.
	Basis of Presentation
	The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its three wholly-owned subsidiaries: FireIce Gel, Inc., GelTech International, Inc. and Weather Tech Innovations, Inc. There has been no activity in Weather Tech Innovations, Inc. and GelTech International, Inc.  These unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for interim financial information. Accordingly, they do not include all of the information and footnotes required by "GAAP" for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The information included in these unaudited condensed consolidated interim financial statements should be read in conjunction with Management's Discussion and Analysis of Financial Conditions and Results of Operations contained in this report and the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended June 30, 2013 filed on September 27, 2013.
	Inventories
	Inventories as of December 31, 2013 consisted of raw materials and finished goods in the amounts of $390,337 and $472,807, respectively.
	Fair Value of Financial Instruments and Fair Value Measurements
	We measure our financial assets and liabilities in accordance with ASC 820 "Fair Value Measurements and Disclosures". For certain of our financial instruments, including cash equivalents, accounts receivable, accounts payable, accrued expenses and line of credit, the carrying amounts approximate fair value due to their short maturities. The carrying amount of our convertible debt approximates the fair value because the interest rate on the convertible note does not vary materially from the market rate for similar debt instruments.
	We adopted accounting guidance for fair value measurements of financial assets and liabilities and adopted the same guidance for non-financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
	Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
	Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
	Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.
	The Company had no financial or non-financial assets or liabilities measured at fair value and subject to this accounting standard as of December 31, 2013 or June 30, 2013.
	Revenue Recognition
	Revenue from sales of products is recognized when persuasive evidence of an arrangement exists, products have been shipped to the customer, economic risk of loss has passed to the customer, the price is fixed or determinable, collection is reasonably assured, and any future obligations of the Company are insignificant.  Revenue is shown net of returns and allowances.  The Company does provide certain customers with the right of return for unsold product.  Sales to these customers are recorded as the customer sells the product, thus removing the right of return.
	Products shipped from either our third-party fulfillment companies or our Jupiter, Florida or Irwindale, California locations are shipped FOB shipping point. Normal payment terms are net 30 or net 60 days depending on the arrangement we have with the customer. As such, revenue is recognized when product has been shipped from either the third-party fulfillment companies or from the Jupiter, Florida or Irwindale, California locations.
	The Company follows the guidance of ASC 605-50-25, "Revenue Recognition, Customer Payments". Accordingly, any incentives received from vendors are recognized as a reduction of the cost of products. Promotional products or samples given to customers or potential customers are recognized as a cost of goods sold.  However, products we utilize to perform demonstrations for potential customers are recorded as a marketing expense in operations. Cash incentives provided to our customers are recognized as a reduction of the related sale price, and, therefore, are a reduction in sales.
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management believes that the estimates utilized in preparing its consolidated financial statements are reasonable; however, actual results could differ materially from these estimates. Significant estimates for the six months ended December 31, 2013 include the allowance for doubtful accounts, depreciation and amortization, valuation of inventories, valuation of options and warrants granted for services or settlements, valuation of common stock granted for services or debt conversion, valuation of debt discount related to the beneficial conversion feature of convertible notes, accruals for litigation losses and the valuation of deferred tax assets.
	Net Earnings (Loss) per Share
	The Company computes net earnings (loss) per share in accordance with ASC 260-10, "Earnings per Share." ASC 260-10 requires presentation of both basic and diluted earnings per share ("EPS") on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period.  Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive.  At December 31, 2013, there were options to purchase 9,808,340 shares of the Company's common stock, warrants to purchase 2,488,112 shares of the Company's common stock and 6,707,094 shares of the Company's common stock are reserved for convertible notes which may dilute future earnings per share.
	Stock-Based Compensation
	The Company accounts for employee stock-based compensation in accordance with ASC 718-10, "Share-Based Payment," which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options, restricted stock units, and employee stock purchases based on estimated fair values.
	Determining Fair Value Under ASC 718-10
	The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing formula. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The Company's determination of fair value using an option-pricing model is affected by the stock price as well as assumptions regarding the number of highly subjective variables.
	The Company estimates volatility based upon the historical stock price of the Company and estimates the expected term for employee stock options using the simplified method for employees and directors and the contractual term for non-employees.  The risk free rate is determined based upon the prevailing rate of United States Treasury securities with similar maturities.
	The fair values of stock option grants for the period from July 1, 2013 to December 31, 2013 were estimated using the following assumptions:
	Risk free interest rate	0.45% - 2.61%
	Expected term (in years)	2.5 - 6.5
	Dividend yield	--
	Volatility of common stock	90.96% - 91.94%
	Estimated annual forfeitures	--
	New Accounting Pronouncements
	Accounting Standards Updates which were not effective until after December 31, 2013 are not expected to have a significant effect on the Company's consolidated financial position or results of operations.

Going_Concern

Going Concern	6 Months Ended
	Dec. 31, 2013
Going Concern [Abstract]	'
Going Concern	'
	NOTE 2 - Going Concern
	These unaudited condensed consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize it assets and discharge its liabilities in the normal course of business.  As of December 31, 2013, the Company had a working capital deficit, an accumulated deficit and stockholders' deficit of $4,585, $31,985,880 and $1,880,313, respectively, and incurred losses from operations of $3,730,330 for the six months ended December 31, 2013 and used cash from operations of $2,769,198 during the six months ended December 31, 2013.  In addition, the Company has not yet generated revenue sufficient to support ongoing operations. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.
	In January 2012, the Company signed a purchase agreement with Lincoln Park Capital Fund LLC which provided for the sale of up to an additional $4.9 million worth of common stock of the Company, in addition to the $100,000 purchased upon entering into the agreement. To date the Company has issued 2,913,997 shares of common stock in exchange for $1,990,003 under this agreement and has the ability to sell another $3.01 million under the agreement.
	Management believes that the actions presently being taken provide the opportunity for the Company to continue as a going concern.  Ultimately, the continuation of the Company as a going concern is dependent upon the ability of the Company to generated sufficient revenue to attain profitable operations. These unaudited condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Convertible_and_NonConvertible

Convertible and Non-Convertible Note Agreements	6 Months Ended
	Dec. 31, 2013
Convertible and Non-Convertible Note Agreements [Abstract]	'
Convertible and Non-Convertible Note Agreements	'
	NOTE 3 - Convertible and Non-Convertible Note Agreements
	On May 29, 2009, the Company received a line of credit ("Line of Credit") from the Company's principal stockholder (the "Lender"). In connection with this Line of Credit, the Company executed a Revolving Promissory Note which permitted the Company to borrow up to $2,500,000. Interest, at an annual rate of 5%, was due monthly on the 20th day of each month which commenced on July 20, 2009.
	In February 2011, the Company renegotiated the Line of Credit Agreement with the Lender. As part of the renegotiation, the Company issued 892,857 shares of the Company's common stock and five-year warrants to purchase 1,000,000 shares of the Company's common stock at an exercise price of $1.25 per share in exchange for a $1,000,000 reduction in the principal amount of the Line of Credit. In addition, the remaining principal amount due under the Line of Credit of $1,497,483 was replaced by a five-year convertible note of the same amount, convertible at $1.12 per share (fair market value on transaction date based upon the quoted trading price) and bearing annual interest of 5%, due on the maturity date of the note (the "2011 Note"). As an inducement for the Lender to enter into the convertible note agreement, the Company granted the Lender five-year warrants to purchase 300,000 shares of the Company's common stock at an exercise price of $1.75 per share. These warrants were exercised in September 2012 in exchange for $150,000 in connection with the Company's offer to all warrant holders to exercise warrants at $0.50 per share instead of the exercise price negotiated on the date of the grant. In February 2013, the 2011 Note, plus a $275,000 convertible original issue discount note were combined into one convertible note agreement, see discussion below.
	In December 2011, the Company received short term advances from its Chief Executive Officer, former President and Chief Financial Officer in the amounts of $10,000, $29,380 and $50,000, respectively. The advances bear interest rates of 0.7%, 5.0% and 5.0%, respectively. In addition, as further inducement for the advance from the Chief Financial Officer, the Company approved the reduction in the exercise price of 150,000 options granted to the Chief Financial Officer from $1.95 to $0.60 per share. In connection with this repricing, the expense related to the vesting of these options was increased by $15,067 which will be recognized over the remaining service period. As of December 31, 2013, the Company has repaid all amounts due on these notes.
	On March 9, 2012, the Company received $105,000 from third parties in exchange for nine month convertible original issue discount notes in the amount of $107,625. The notes bear an annual interest rate of 5% and are convertible into the Company's common stock at the rate of $0.50 per share. In connection with the issuance of the notes, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $84,562 which will be amortized to interest expense over the life of the notes. In September 2012, the Company issued new one-year convertible original issue discount notes in the amount of $120,540, bearing annual interest of 12% and convertible at $0.50 per share in exchange for cancellation of the old notes. This modification was not considered a debt extinguishment.  In accordance with ASC 470, the Company recognized a debt discount related to the change in fair value of the embedded conversion option in the amount of $35,138 which was amortized to interest expense over the life of the convertible notes.  In August 2013, the Company paid one note in the amount of $34,440 by issuing 8,880 shares of common stock and a payment of $30,000.  The remaining note in the amount of $86,100 was paid early by the payment of $85,822.
	On March 10, 2012, the Company received $75,000 from a director in exchange for a six month convertible original issue discount note in the amount of $76,875. The note bears an annual interest rate of 5% and is convertible into the Company's common stock at the rate of $0.50 per share. In connection with the issuance of the note, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $63,038 was amortized to interest expense over the life of the note. In September 2012, the Company issued a new one-year convertible original issue discount note in the amount of $86,100, bearing annual interest of 12% and convertible at $0.50 per share in exchange for cancellation of the old note. This modification was not considered a debt extinguishment. In accordance with ASC 470, the Company will recognize a debt discount related to the change in fair value of the embedded conversion option in the amount of $24,971 which was amortized to interest expense over the life of the convertible note.  In September 2013, the Company repaid the note.
	In August 2012, the Company received $75,000 in exchange for a six month convertible original issue discount note in the amount of $76,875 with an accredited investor. The note is convertible into common stock at $0.50 per share and bears an annual interest rate of 5% and is convertible into the Company's common stock at the rate of $0.50 per share.  In connection with the issuance of the notes, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $1,875 and an original issue discount of $55,350 which will be amortized to interest expense over the life of the notes. In February 2013, the note holder was issued a new one year original issue discount note for $86,100 convertible at $0.35 per share. The Company recorded an original issue discount of $9,225 and a beneficial conversion feature discount of $4,920 in connection with the new note. In August 2013, the Company issued 234,663 shares of common stock in connection with the early conversion of this note.
	On December 28, 2012, the Company received $250,000 from its principal stockholder in exchange for a one year convertible original issue discount note in the amount of $275,000 (the "2012 Note"). The note bears an annual interest rate of 10% and is convertible into the Company's common stock at the rate of $0.35 per share. In connection with the issuance of the note, the Company recorded a loan discount related to the intrinsic value of the beneficial conversion feature in the amount of $23,571 and an original issue discount of $25,000 which will be amortized to interest expense over the life of the note.
	In February 2013, the Company entered into a new convertible note agreement in the amount of $1,997,483, convertible into common stock at a conversion price of $0.35 per share, bearing interest at an annual rate of 7.5% and due on December 31, 2016. This note was issued in exchange for the 2011 Note and the 2012 Note and receipt of $250,000. In connection with the transaction, the Company issued 210,226 shares of common stock in exchange for accrued interest of $73,579 due on the 2011 and 2012 notes resulting in a loss on conversion of interest of $4,204. The exchange of cash and the 2011 and 2012 notes was recorded as a debt extinguishment which resulted in a loss on extinguishment of debt in the amount of $21,311 for the year ended June 30, 2013. Because this convertible debt  instrument contained an embedded beneficial conversion feature, and was extinguished before conversion, the amount of the reacquisition price to be allocated to the repurchased beneficial feature was measured using the intrinsic value of that conversion feature at the extinguishment date and was immaterial. In connection with the new note agreement, the Company recorded a note discount in the amount of $114,142 related to the beneficial conversion feature of the note calculated using the intrinsic value, of which $35,703 has been amortized as of December 31, 2013.
	In July 2013, the Company received $1 million from its Chief Operating Officer and principal stockholder in exchange for a five year, $1 million convertible note with a conversion rate of $1.00 per share and an annual interest of 7.5%, plus five year warrants to purchase 500,000 shares of the common stock at $1.30 per share. The Company calculated the relative fair market value of the warrants to be $311,949 using the Black-Scholes model using a volatility of 91.46% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 5 years (the term of the warrants) and a discount rate of 1.4%. In addition, the Company calculated the intrinsic value of the beneficial conversion feature of the note to be $601,949. As of December 31, 2013, the Company recognized interest expense from the amortization of the debt discounts related to this note in the amount of $86,632.

Stockholders_Equity

Stockholders' Equity	6 Months Ended
	Dec. 31, 2013
Stockholders' Equity [Abstract]	'
Stockholders' Equity	'
	NOTE 4 - Stockholders' Equity
	Preferred Stock
	The Company has authorized 5,000,000 shares of preferred stock, par value $0.001 per share with such rights, preferences and limitation as may be set from time to time by resolution of the board of directors and the filing of a certificate of designation as required by Delaware General Corporation Law.
	Common Stock
	The issuances of common stock during the six months ended December 31, 2013 were as follows:
	In July 2013, the Company issued 20,000 shares of common stock to a director in exchange for $18,200 in connection with the exercise of options at an exercise price of $0.91 per share.
	In August 2013, the Company issued 20,000 shares of common stock in exchange for $25,000 in connection with the exercise of warrants with an exercise price of $1.25 per share.
	In August 2013, the Company issued 234,663 shares of common stock in connection with the early conversion of a convertible note in the amount of $82,132.
	In October 2013, the Company issued 400,000 shares of common stock and five year warrants to purchase 200,000 shares of common stock at an exercise price of $1.00 per share in exchange for $300,000 in connection with a private placement with a director and his wife.
	In October 2013, the Company issued 200,000 shares of common stock and five year warrants to purchase 100,000 shares of common stock at an exercise price of $1.00 per share in exchange for $150,000 in connection with a private placement with its COO and principal shareholder.
	During the six months ended December 31, 2013, the Company issued 357,647 shares of common stock and five year warrants to purchase 149,412 shares of common stock at exercise prices between $1.00 and $1.25 per share in exchange for $280,000 in connection with private placements with four accredited investors.
	During the six months ended December 31, 2013, the Company issued 577,428 shares of common stock in exchange for $570,000 in connection with the Purchase Agreement with Lincoln Park Capital.
	During the six months ended December 31, 2013, the Company issued 263,204 shares of common stock in exchange for $225,000 in connection with private placements with five accredited investors.
	During the six months ended December 31, 2013, the Company issued 829,546 shares of common stock in exchange for $550,000 in connection with private placements with its COO and Principal Shareholder.
	Options to Purchase Common Stock
	Stock-based compensation expense recognized under ASC 718-10 for the period July 1, 2013 to December 31, 2013 was $1,235,650 for stock options granted to employees and directors. This expense is included in selling, general and administrative expenses in the unaudited condensed consolidated statements of operations. Stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. At December 31, 2013, the total compensation cost for stock options not yet recognized was approximately $1,659,670. This cost will be recognized over the remaining vesting term of the options of approximately three years.
	A summary of stock option transactions for all employee stock options for the six month periods ended December 31, 2013 and 2012 is as follows:
	Employee Options and Stock Appreciation Rights
		Number of			Weighted		Weighted		Aggregate
		Options			Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Life
	Balance at June 30, 2012		4,589,507		$	1.04		5.95
	Granted		4,135,000		$	0.5		9.6
	Exercised		-		$	-		-
	Forfeited		(750,000	)	$	1.25
	Expired				$			-
	Outstanding at December 31, 2012		7,974,507		$	0.77		6.93	$	-
	Exercisable at December 31, 2012		4,500,257		$	0.89		5.9	$	-
	Weighted average fair value of options granted during the six months ended December 31, 2012.				$	0.37
	Balance at June 30, 2013		6,337,007		$	0.75		8.25
	Granted		1,215,500		$	1.35		9.2
	Exercised		-		$	-		-
	Forfeited		-		$	-		-
	Expired		-		$	-
	Outstanding at December 31, 2013		7,552,507		$	0.86		6.48	$	692,330
	Exercisable at December 31, 2013		4,170,173		$	0.94		4.92	$	222,689
	Weighted average fair value of options granted during the six months ended December 31, 2013				$	0.69
	A summary of options issued to non-employees under the 2007 Plan and changes during the period from June 30, 2012 to December 31, 2012 and from June 30, 2013 to December 31, 2013 is as follows:
	On September 21, 2012, the Company granted options to purchase 70,000 shares of the Company's common stock at an exercise price of $0.63 per share to the father of the Company's CEO and CTO in recognition of his service. Of the options granted, 35,000 vest immediately with the remainder vesting semi-annually each December 31 and June 30 over a three year period, subject to continued employment on the vesting date. The Company valued the options at $28,358 using the Black-Scholes option pricing model using a volatility of 90.09%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 4 years, using the Simplified Method and a discount rate of 0.53%.
	On September 25, 2012, the Compensation Committee of the Board of Directors approved the granting of five-year options to purchase 265,000 shares of common stock at an exercise price of $0.60 per share to non-executive employees. The options vest 25% immediately with the remainder vesting annually over three years, subject to continued employment. The Company valued the options at $101,029 using the Black-Scholes option pricing model using a volatility of 89.93%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 4 years, using the Simplified Method and a discount rate of 0.53%. The resulting expense will be recognized 25% immediately and the remainder over the vesting period.
	On November 14, 2012 , the Compensation Committee of the Board of Directors granted its Chief Executive Officer, Chief Financial Officer, Chief Technology Officer and President 800,000 each stock settled stock appreciation rights ("SARS") of which (i) 200,000 vested immediately, (ii) 200,000 vest upon the Company generating $3,000,000 in revenue in any 12-month period, (iii) another 200,000 vest upon the Company generating $5,000,000 in revenue in any 12-month period and (iv) another 200,000 vest upon the Company generating $6,000,000 in revenue in any 12-month period. The SARs are exercisable at $0.45 per share over a 10-year period. The Company valued the SARS at $1,086,560 using the Black-Scholes option pricing model using a volatility of 89.67%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 6.5 years, using the Simplified Method and a discount rate of 0.93%.  The resulting expense will be recognized 25% immediately and the remainder over the vesting period.  The Company's Chief Executive Officer, President and Chief Technology Officer agreed to cancel the 250,000 stock options granted to each of them in their prior employment agreements.
	In July 2013, the Company issued ten year options to purchase 250,000 shares of common stock, each to its Chief Executive Officer, Chief Technology Officer and Chief Financial Officer. The options have an exercise price of $1.30 per share and vest 50% upon the market value of the Company's common stock trading at or greater than $2.00 per share for any 10 day period out of a 30 day trading period and the other 50% vesting upon the market value of the Company's common stock trading at or greater than $3.00 per share for any 10 day period out of a 30 day trading period.  The options were valued using the Black-Scholes model using a volatility of 93.11% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 2.62%. The value of these options was estimated by management in accordance with ASC 718, which requires an estimate of the probability that these market conditions will occur and for the resulting discounted value be expensed immediately. Accordingly management has expensed $63,180 to stock compensation expense.
	In July 2013, the Company granted 100,000 options to a new employee in connection with his employment.  Of the options granted, 50,000 are exercisable at $1.25 per share and 50,000 are exercisable at $1.75 per share.  Both grants are for a five year term vest 25% immediately and 75% in equal amounts over three years.  The options were valued using the Black-Scholes model using a volatility of 91.61% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 4.0 years (using the simplified method) and a discount rate of 1.14%. The value of these options, $80,413 will be recognized as expense over the requisite service period.
	In July 2013, the Company granted ten year options to purchase 25,000 shares of the Company's common stock at an exercise price of $1.30 per share to the father of the Company's CEO and CTO in recognition of his service. The options vest over a three year period. The Company valued the options at $25,272 using the Black-Scholes option pricing model using a volatility of 91.72%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 1.5 years, using the Simplified Method and a discount rate of 2.61%.
	In July 2013, the Board of Directors approved a pool of 400,000 options to be granted to employees at the discretion of the executive management of the Company.  In September 2013, management granted 100,000 of these options to employees.  The options vested immediately, are exercisable for five years and have an exercise price of $1.30 per share, the market value of our common stock on the date of the grant.  The Company valued the options at $69,452 using the Black-Scholes option pricing model using a volatility of 91.72%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.45%.  In December 2013, management granted 90,500 of these options to employees.  The options vested immediately, are exercisable for five years and have an exercise price of $0.72 per share, the market value of our common stock on the date of the grant.  The Company valued the options at $34,610 using the Black-Scholes option pricing model using a volatility of 90.96%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.55%.
	In August 2013, the Company granted 150,000 stock settled Stock Appreciation Rights (SARS) to a new employee in connection with his employment.  The SARS are exercisable at 1.52 per share, are for a five year term and vest 50,000 immediately and the remaining options will vest 33,334 upon the Company reaching $3 million in sales in any twelve month period, 33,333 upon the Company reaching sales of $5 million in any twelve month period and 33,333 upon the Company reaching sales of $6 million in any twelve month period.  The SARS were valued using the Black-Scholes model using a volatility of 91.91% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 4.0 years (using the simplified method) and a discount rate of 1.97%. The value of these SARS, $176,413 will be recognized as expense over the period required to meet the performance criteria which is estimated to be approximately two years.
	A summary of options issued to directors under the 2007 Plan and changes during the period from June 30, 2012 to December 31, 2012 and from June 30, 2013 to December 31, 2013 is as follows:
	Options Issued to Directors
		Number of			Weighted		Weighted		Aggregate
		Options			Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Life
	Balance at June 30, 2012		857,500		$	1.36		7.96
	Granted		235,000		$	0.9		10
	Exercised		-		$	-		-
	Forfeited		-		$	-		-
	Expired		-		$	-		-
	Outstanding at December 31, 2012		1,092,500		$	1.26		7.9	$	-
	Exercisable at December 31, 2012		756831		$	1.38		7.37	$	-
	Weighted average fair value of options granted during the six months ended December 31, 2012				$	0.65
Balance at June 30, 2013		1,200,833		$	1.16		8.04
Granted		495,000		$	1.19		10
Exercised		(20,000	)	$	0.91		-
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at December 31, 2013		1,675,833		$	1.12		8.11	$	6,287
Exercisable at December 31, 2013		885,835		$	1.23		6.98	$	5,154
Weighted average fair value of options granted during the six months ended December 31, 2013				$	0.76
On July 1, 2012, the Company issued options to purchase 230,000 shares of common stock to directors. The options have an exercise price of $0.91 per share, vest on June 30, 2013¸ subject to continuing service as a director and bear a ten year term. The options were valued using the Black-Scholes model using a volatility of 91.04% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 5.5 years (using the simplified method) and a discount rate of 0.82%. The value of these options will be recognized as expense over the requisite service period.
On December 6, 2012, the Company issued options to purchase 5,000 shares of common stock to a director upon his appointment to the audit committee. The options have an exercise price of $0.36 per share, and vest over three years, subject to continued service and bear a ten year term. The options were valued using the Black-Scholes model using a volatility of 89.86% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 0.90%. The value of these options, $1,360, will be recognized as expense over the requisite service period.
As prescribed by the Company's 2007 Equity Incentive Plan, on July 1, 2013, the Company issued options to purchase 370,000 shares of common stock to directors. The options have an exercise price of $1.15 per share, vest on June 30, 2014¸ subject to continuing service as a director and bear a ten year term.  The options were valued using the Black-Scholes model using a volatility of 93.11% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 5.5 years (using the simplified method) and a discount rate of 1.52%. The value of these options will be recognized as expense over the requisite service period.
In July 2013, the Company issued ten year options to purchase 50,000 shares of common stock to a director. The options have an exercise price of $1.30 per share and vested immediately.  The options were valued using the Black-Scholes model using a volatility of 93.11% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 2.67%. The value of these options will be recognized as expense during the six months ended December 31, 2013.
In September 2013, the Company issued ten year options to purchase 15,000 shares of common stock to a director. The options have an exercise price of $1.01 per share and vested immediately.  The options were valued using the Black-Scholes model using a volatility of 91.6% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 5.0 years (using the simplified method) and a discount rate of 1.62%. The value of these options, $10,702, was recognized as expense during the six months ended December 31, 2013.
In October 2013, the Company issued ten year options to purchase 60,000 shares of common stock at an exercise price of $1.17 per share to a new director.  The options vest annually subject to continued service.  The options were valued using the Black-Scholes model using a volatility of 91.94% (derived using the historical market price for the Company's common stock since it began trading in June 2008), an expected term of 6.5 years (using the simplified method) and a discount rate of 1.89%. The value of these options, $54,285 will be recognized as expense over the vesting period.
A summary of options issued to non-employees under the 2007 Plan and changes during the six month periods from June 30, 2012 to December 31, 2012 and from June 30, 2013 to December 31, 2013 is as follows:
Non-Employee, Non-Director Options
	Number of			Weighted		Weighted		Aggregate
	Options			Average		Average		Intrinsic
				Exercise		Remaining		Value
				Price		Contractual
						Life
Balance at June 30, 2012		540,000		$	1.16		3.14
Granted		-		$	-		-
Exercised		(100,000	)	$	0.5
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at December 31, 2012		440,000		$	1.14		1.77	$	-
Exercisable at December 31, 2012		440,000		$	1.14		1.77	$	-
Weighted average fair value of options granted during the six months ended December 31, 2012					N/A
Balance at June 30, 2013		560,000		$	1.22		5.96
Granted		20,000		$	1.18		5
Exercised		-		$	-		-
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at December 31, 2013		580,000		$	1.22		5.43	$	-
Exercisable at December 31, 2013		305,000		$	1.21		1.92	$	-
Weighted average fair value of options granted during the six months ended December 31, 2013				$	0.96
In September 2012, the Company issued 100,000 shares of common stock in exchange for $50,000 in connection with the exercise of 100,000 options to purchase shares of the Company's common stock related to an offer by the Company to reduce the exercise price to $0.50 per share. The original exercise price of the options was $1.25 per share. The Company recognized a loss resulting from the reduction of the exercise price of the options exercised in the amount of $391 representing the difference in the fair market value of the repriced options as compared to the fair market value of the original options on the exercise date. The fair market value of the options was determined using the Black-Scholes options pricing model.
In October 2013, the Company granted five-year options to purchase 20,000 shares of common stock
at an exercise price of $1.18 per share to two consultants.  The Company valued the options at $16,670 using the Black-Scholes option pricing model using a volatility of 91.94%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 5.0 years, the term of the options and a discount rate of 1.38%.
Warrants to Purchase Common Stock
The Company accounts for warrants issued for services in accordance with ASC 505-50-30-2 Equity Based Payments to Non-Employees.  As such, the Company calculates the fair value of the warrants granted using the Black-Scholes option pricing model and records the fair value to either prepaid expense or expense based upon the terms of the underlying contract for services.  In applying the Black-Scholes method, the Company calculates volatility based upon the historical market price of the Company's common stock, utilizes discount rates obtained from the Federal Reserve Statistical Release for treasury instruments of the same duration and expected term as the contractual term of the warrants.
Warrants issued in connection with the sale of shares of common stock are treated as part of the equity transaction and are recorded in stockholders' equity or liabilities in accordance with the guidance at ASC 480-10-25.
A summary of warrants issued for settlements and changes during the periods July 1, 2012 to December 31, 2012 and from July 1, 2013 to December 31, 2013 is as follows:
Warrants Issued as Settlements
	Number of			Weighted		Remaining
	Warrants			Average		Contractual
				Exercise		Life
				Price
Balance at June 30, 2012		344,058		$	1.05		0.92
Granted		350,000		$	0.6		5
Exercised		-		$	-		-
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at December 31, 2012		694,058		$	0.84		2.58
Exercisable at December 31, 2012		694,058		$	0.84		2.58
Weighted average fair value of options granted during the six months ended December 31, 2012				$	0.33
Balance at June 30, 2013		350,000		$	0.63		4.22
Granted		-		$	-		-
Exercised		-		$	-		-
Forfeited		-		$	-		-
Expired		-		$	-		-
Outstanding at December 31, 2013		350,000		$	0.63		3.74
Exercisable at December 31, 2013		350,000		$	0.63		3.74
Weighted average fair value of options granted during the six months ended December 31, 2013					N/A
On September 21, 2012, the Board of Directors granted five year warrants to purchase 350,000 shares of the Company's common stock at an exercise price of $0.63 per share to a director in recognition of his exemplary five years of service to the Company. The warrants vested immediately. The Company valued the warrants at $115,883 using the Black-Scholes option pricing model using a volatility of 90.09%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 2.5 years, using the Simplified Method and a discount rate of 0.32%.
A summary of warrants issued for cash and changes during the periods June 30, 2012 to December 31, 2012 and from June 30, 2013 to December 31, 2013 is as follows:
Warrants issued for cash or services
	Number of			Weighted		Remaining
	Warrants			Average		Contractual
				Exercise		Life
				Price
Balance at June 30, 2012		4,481,200		$	1.46		2.46
Granted		50,000		$	0.63		5
Exercised		(1,820,000	)	$	0.5		-
Exercise rescission		-		$	-
Forfeited		-		$	-		-
Expired		(320,000	)	$	1.6		-
Outstanding at December 31, 2012		2,391,200		$	1.42		1
Exercisable at December 31, 2012		2,91,200		$	1.42		1
Weighted average fair value of options granted during the six months ended December 31, 2012				$	0.44
Balance at June 30, 2013		1,533,700		$	1.25		2.06
Granted		949,412		$	1.17		5
Exercised		(20,000	)	$	1.25		-
Forfeited		-		$	-		-
Expired		(325,000	)	$	1.25		-
Outstanding at December 31, 2013		2,138,112		$	1.22		3.46
Exercisable at December 31, 2013		2,138,112		$	1.22		3.46
Weighted average fair value of options granted during the six months ended December 31, 2013					N/A
On September 21, 2012, the Board of Directors granted five year warrants to purchase 50,000 shares of the Company's common stock at an exercise price of $0.63 per share to the Company's Investor Relations firm in recognition of their performance over the past year. The warrants vested immediately. The Company valued the warrants at $21,787 using the Black-Scholes option pricing model using a volatility of 90.09%, based upon the historical price of the Company's common stock since June 2008, an estimated term of 5 years, the term of the warrants, and a discount rate of 0.70%.
During the six months ended December 31, 2012, the Company issued 1,820,000 shares of common stock in exchange for $910,000 in connection with the exercise of 1,820,000 warrants to purchase shares of the Company's common stock related to an offer by the Company to reduce the exercise price to $0.50 per share. The original exercise prices of the warrants ranged from $1.25 to $1.75 per share. The cost of repricing warrants recognized by the Company amounted to $70,491 for the six months ended December 31, 2012. The cost represents the incremental increase in the fair value of the repriced warrants as compared to the original warrants granted, valued on the exercise date.  The fair value of the warrants was determined using the Black-Scholes option pricing model.
During December 2012, warrants to purchase 320,000 shares of the Company's common stock at an exercise price of $1.60 per share expired unexercised.
In July 2013, the Company issued five year warrants to purchase 29,412 shares of common stock at an exercise price of $1.30 per share in connection with a private placement with an accredited investor.
In July 2013, the Company issued five year warrants to purchase 500,000 shares of common stock at an exercise price of $1.30 per share to its principal stockholder in connection with a $1 .0 million convertible note agreement.
In August 2013, the Company issued 20,000 shares of common stock in exchange for $25,000 in connection with the exercise of warrants with an exercise price of $1.25 per share.
In October 2013, the Company issued five year warrants to purchase 100,000 shares of common stock at an exercise price of $1.00 per share in connection with a private placement with its Principal Shareholder.
In October 2013, the Company issued five year warrants to purchase 200,000 shares of common stock at an exercise price of $1.00 per share in connection with private placements a director and his wife.
In October 2013, the Company issued five year warrants to purchase 120,000 shares of common stock at an exercise price of $1.00 per share in connection with private placements with three accredited investors.

Commitments_and_Contingencies

Commitments and Contingencies	6 Months Ended
	Dec. 31, 2013
Commitments and Contingencies [Abstract]	'
Commitments and Contingencies	'
	NOTE 5 - Commitments and Contingencies
	The Company leases office and warehouse space located in Jupiter, Florida under a month-to-month lease and leases space in an industrial yard in Irvine, California under a one year lease which commenced in June 2011 and leases a facility in Brooklyn under a one year lease that began in February 2013.
	Rent expense for the six months ended December 31, 2013 and 2012 was $84,009 and $53,479, respectively.
	On November 14, 2012, the Compensation Committee approved new employment agreements for the Company's then Chief Executive Officer, then President, Chief Technology Officer and Chief Financial Officer. The employment agreements each provided for base salaries of $150,000 and 800,000 stock settled stock appreciation rights ("SARS") of which (i) 200,000 vested immediately, (ii) 200,000 vest upon the Company generating $3,000,000 in revenue in any 12-month period, (iii) another 200,000 vest upon the Company generating $5,000,000 in revenue in any 12-month period and (iv) another 200,000 vest upon the Company generating $6,000,000 in revenue in any 12-month period. The SARs are exercisable at $0.45 per share over a 10-year period. The Company's then Chief Executive Officer, then President and Chief Technology Officer agreed to cancel the 250,000 stock options granted to each of them in their prior employment agreements. These executives' base salary will increase to: (i) $170,000 upon the Company generating $3,000,000 in revenue in any 12-month period, (ii) $190,000 upon the Company generating $5,000,000 in any 12-month period and (iii) $200,000 upon the Company generating $6,000,000 in any 12-month period.
	Additionally, the Compensation Committee approved an employment agreement for the Company's Executive Chairman. The Executive Chairman receives a base salary of $200,000 per year and was granted 800,000 restricted stock units vesting on identical terms as the SARs. All of the five senior executives receive a monthly car allowance of $600 per month. The Compensation Committee will also have the discretion to award each of the executives a bonus based upon job performance, revenue growth or any other factors determined by the Compensation Committee. Each of the employment agreements was effective as of October 1, 2012 and is for a four-year term. In June 2013, the Company terminated this agreement for cause.
	The Company was sued by a former employee on June 23, 2008, alleging breach of a consulting agreement and an employment agreement entered into in May and June 2007, respectively. In addition, the plaintiff seeks to recover certain of his personal property, which was used or stored in the Company's offices, and alleges the Company invaded his privacy by looking at his personal computer (which was used in the Company's business) in the Company's offices. A jury trial was held for the lawsuit in July 2012. At the conclusion of the trial, the plaintiff was awarded $200,000 under his invasion of privacy and fraudulent misrepresentation claim, $5,000 on the trespass claim,$841,000 on the breach of consulting agreement claim and $200,000 against the Company's CEO on a claim of civil theft, which by law results in an award of $600,000 for the plaintiff. The Company's board of directors approved the indemnification of the Company's CEO for the $600,000. The Company filed a post trial motion for Judgment Notwithstanding Verdict, New Trial and Remittitur, requesting that the judge set aside or reduce the amounts of the jury verdict.
	Based upon the verdicts, the Company recorded a litigation accrual of $1,646,000 as of June 30, 2012. In November 2012, the insurance carrier paid the plaintiff $200,000 in settlement of the invasion of privacy and fraudulent misrepresentation awards. As a result, the Company reduced the amounts accrued for these awards resulting in other income of $200,000 for the period ended December 31, 2012.
	In January 2013, the court ruled on the Company's post-trial motions in this litigation dismissing the $200,000 civil theft verdict (which was subject to triple damages) against the CEO and reducing the $841,000 breach of the consulting agreement award to $500,000. The Company then filed a motion seeking a new trial on damages. The Company received a favorable ruling on this motion and received a new trial on the damages. As a result of the reduction in the award for breach of the consulting agreement from $841,000 to $500,000 and the vacating of the award for civil theft which the Company had previously accrued $600,000, the Company recorded other income of $941,000 for the year ended June 30, 2013.  The Company expects the trial to determine damages to occur in the spring of 2014.

Related_Party_Transactions

Related Party Transactions	6 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	NOTE 6 - Related Party Transactions
	In addition to the Chief Executive Officer (CEO) and the Chief Technology Officer (CTO) the following related parties are employed at GelTech:
	·
	The CEO's wife is a bookkeeper at $1,200 per week,
	·
	The CEO and CTO's father is a researcher at $2,123 per week, and
	·
	The CEO and CTO's mother is a receptionist at $600 per week.
	The Company has employment arrangements with its executive officers which are described under Note 5.
	The Company has entered into a series of credit facilities with its principal stockholder as more fully described in Note 3.
	In September 2012 and July 2013,  the Company granted options to purchase 70,000 shares and 25,000 shares, respectively, of the Company's common stock to the father of the Company's CEO and CTO as more fully described in Note 4.
	In September 2012, the Company granted warrants to purchase 350,000 shares of the Company's common stock to a director as more fully described in Note 4.
	Effective February 8, 2013, the Company's President and Director resigned from the Company to pursue other opportunities. In connection with his separation, the Company agreed to pay the former President $150,000 plus COBRA payments over 14 months. In addition, the Company agreed to issue the former President ten year fully vested options to purchase 112,500 shares of the Company's common stock at an exercise price of $0.39 per share, subject to a lockup agreement for the option shares and the other shares he currently owns. In addition, options and stock appreciation rights to purchase 2,125,000 shares of the Company's common stock at exercise prices from $0.45 to $1.22 per share, previously issued to him, were cancelled. The Company recognized a severance expense of $168,920 upon the signing of the agreement representing the total liability to the Company under the severance agreement. As of December 31, 2013, the remaining liability under the agreement amounted to $59,826.
	In September 2013, the father of  the Company's Chief Operating Officer and principal stockholder was appointed to the board of directors.

Concentrations

Concentrations	6 Months Ended
	Dec. 31, 2013
Concentrations [Abstract]	'
Concentrations	'
	NOTE 7 - Concentrations
	The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through December 31, 2013. As of December 31, 2013, there were no cash equivalent balances held in depository accounts that are not insured.
	At December 31, 2013, three customers accounted for 48.4%, 17.7% and 14.0% of accounts receivable.
	For the six months ended December 31, 2013 one customer accounted for approximately 76.9% of sales.
	During the six months ended December 31, 2013 all sales resulted from two products, FireIce® and Soil2O™ which made up 89.03% and 11.0%, respectively, of total sales. Of the FireIce® sales, 80.2% related to the sale of EMFIDS, 16.6% related to the sale of FireIce® products, 1.93% related to paid for research and 1.3%% related to sales of the FireIce Home Defense units. Of the Soil2O™ sales, 1.3%% related to traditional sales of Soil2O® and 98.7% related to sales of Soil2O® Dust Control.
	Four vendors accounted for 36.1%, 17.1%, 13.6% and 11.3% of the Company's approximately $471,000 of EMFIDS parts, raw material and packaging purchases during the six months ended December 31, 2013.

Subsequent_Events

Subsequent Events	6 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	NOTE 8 - Subsequent Events
	In January 2014, the Company's shareholders approved increasing the number of authorized shares of common stock to 100,000,000. Effective January 21, 2014, the Company's authorized common stock was increased to 100,000,000 shares.
	On January 21, 2014, our former Chief Executive Officer (who had taken a leave of absence) passed away. His estate will receive one-year's severance and all stock options and SARS will continue to vest as provided in the respective agreements.
	Since January 1, 2014 the Company has issued 1,417,056 shares of common stock in exchange for $832,875 in connection with private placements with seven accredited investors.

Organization_and_Basis_of_Pres1

Organization and Basis of Presentation (Policy)	6 Months Ended
	Dec. 31, 2013
Organization and Basis of Presentation [Abstract]	'
Organization	'
	Organization
	GelTech Solutions, Inc., or GelTech, markets the following products: (1) FireIce®, a water enhancing powder that can be utilized both as a fire suppressant in urban firefighting, including underground utility fires, and in wildland firefighting and as a medium-term fire retardant to protect wildlands, structures and firefighters; (2) Emergency Manhole FireIce Delivery System, or EMFIDS, an innovative system designed to deliver FireIce® into a manhole in the event of a fire; (3) FireIce® Home Defense Unit, a system for applying FireIce® to structures to protect them from wildfires; (4) Soil2O® "Dust Control", our new application which is used for dust mitigation in the aggregate, road construction, mining, as well as, other industries that deal with daily dust control issues; and (5) Soil2O®, a product which reduces the use of water and is primarily marketed to golf courses, commercial landscapers and the agriculture market.  Our financial statements have been prepared on a going concern basis, and we need to generate sufficient material revenues to support the ongoing business of GelTech.
	The corporate office is located in Jupiter, Florida.
Basis of Presentation	'
	Basis of Presentation
	The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its three wholly-owned subsidiaries: FireIce Gel, Inc., GelTech International, Inc. and Weather Tech Innovations, Inc. There has been no activity in Weather Tech Innovations, Inc. and GelTech International, Inc.  These unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for interim financial information. Accordingly, they do not include all of the information and footnotes required by "GAAP" for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The information included in these unaudited condensed consolidated interim financial statements should be read in conjunction with Management's Discussion and Analysis of Financial Conditions and Results of Operations contained in this report and the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended June 30, 2013 filed on September 27, 2013.
Inventories	'
	Inventories
	Inventories as of December 31, 2013 consisted of raw materials and finished goods in the amounts of $390,337 and $472,807, respectively.
Fair Value of Financial Instruments and Fair Value Measurements	'
	Fair Value of Financial Instruments and Fair Value Measurements
	We measure our financial assets and liabilities in accordance with ASC 820 "Fair Value Measurements and Disclosures". For certain of our financial instruments, including cash equivalents, accounts receivable, accounts payable, accrued expenses and line of credit, the carrying amounts approximate fair value due to their short maturities. The carrying amount of our convertible debt approximates the fair value because the interest rate on the convertible note does not vary materially from the market rate for similar debt instruments.
	We adopted accounting guidance for fair value measurements of financial assets and liabilities and adopted the same guidance for non-financial assets and liabilities. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
	Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
	Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
	Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.
	The Company had no financial or non-financial assets or liabilities measured at fair value and subject to this accounting standard as of December 31, 2013 or June 30, 2013.
Revenue Recognition	'
	Revenue Recognition
	Revenue from sales of products is recognized when persuasive evidence of an arrangement exists, products have been shipped to the customer, economic risk of loss has passed to the customer, the price is fixed or determinable, collection is reasonably assured, and any future obligations of the Company are insignificant.  Revenue is shown net of returns and allowances.  The Company does provide certain customers with the right of return for unsold product.  Sales to these customers are recorded as the customer sells the product, thus removing the right of return.
	Products shipped from either our third-party fulfillment companies or our Jupiter, Florida or Irwindale, California locations are shipped FOB shipping point. Normal payment terms are net 30 or net 60 days depending on the arrangement we have with the customer. As such, revenue is recognized when product has been shipped from either the third-party fulfillment companies or from the Jupiter, Florida or Irwindale, California locations.
	The Company follows the guidance of ASC 605-50-25, "Revenue Recognition, Customer Payments". Accordingly, any incentives received from vendors are recognized as a reduction of the cost of products. Promotional products or samples given to customers or potential customers are recognized as a cost of goods sold.  However, products we utilize to perform demonstrations for potential customers are recorded as a marketing expense in operations. Cash incentives provided to our customers are recognized as a reduction of the related sale price, and, therefore, are a reduction in sales.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management believes that the estimates utilized in preparing its consolidated financial statements are reasonable; however, actual results could differ materially from these estimates. Significant estimates for the six months ended December 31, 2013 include the allowance for doubtful accounts, depreciation and amortization, valuation of inventories, valuation of options and warrants granted for services or settlements, valuation of common stock granted for services or debt conversion, valuation of debt discount related to the beneficial conversion feature of convertible notes, accruals for litigation losses and the valuation of deferred tax assets.
Net Earnings (Loss) per Share	'
	Net Earnings (Loss) per Share
	The Company computes net earnings (loss) per share in accordance with ASC 260-10, "Earnings per Share." ASC 260-10 requires presentation of both basic and diluted earnings per share ("EPS") on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period.  Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive.  At December 31, 2013, there were options to purchase 9,808,340 shares of the Company's common stock, warrants to purchase 2,488,112 shares of the Company's common stock and 6,707,094 shares of the Company's common stock are reserved for convertible notes which may dilute future earnings per share.
Stock-Based Compensation	'
	Stock-Based Compensation
	The Company accounts for employee stock-based compensation in accordance with ASC 718-10, "Share-Based Payment," which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors including employee stock options, restricted stock units, and employee stock purchases based on estimated fair values.
	Determining Fair Value Under ASC 718-10
	The Company estimates the fair value of stock options granted using the Black-Scholes option-pricing formula. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The Company's determination of fair value using an option-pricing model is affected by the stock price as well as assumptions regarding the number of highly subjective variables.
	The Company estimates volatility based upon the historical stock price of the Company and estimates the expected term for employee stock options using the simplified method for employees and directors and the contractual term for non-employees.  The risk free rate is determined based upon the prevailing rate of United States Treasury securities with similar maturities.
	The fair values of stock option grants for the period from July 1, 2013 to December 31, 2013 were estimated using the following assumptions:
	Risk free interest rate	0.45% - 2.61%
	Expected term (in years)	2.5 - 6.5
	Dividend yield	--
	Volatility of common stock	90.96% - 91.94%
	Estimated annual forfeitures	--
New Accounting Pronouncements	'
	New Accounting Pronouncements
	Accounting Standards Updates which were not effective until after December 31, 2013 are not expected to have a significant effect on the Company's consolidated financial position or results of operations.

Organization_and_Basis_of_Pres2

Organization and Basis of Presentation (Tables)	6 Months Ended
	Dec. 31, 2013
Organization and Basis of Presentation [Abstract]	'
Schedule of Fair Value Assumptions for Stock Options	'
	The fair values of stock option grants for the period from July 1, 2013 to December 31, 2013 were estimated using the following assumptions:
	Risk free interest rate	0.45% - 2.61%
	Expected term (in years)	2.5 - 6.5
	Dividend yield	--
	Volatility of common stock	90.96% - 91.94%
	Estimated annual forfeitures	--

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	6 Months Ended
	Dec. 31, 2013
Employee Options and Stock Appreciation Rights [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of Options Activity	'
	A summary of stock option transactions for all employee stock options for the six month periods ended December 31, 2013 and 2012 is as follows:
	Employee Options and Stock Appreciation Rights
		Number of			Weighted		Weighted		Aggregate
		Options			Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Life
	Balance at June 30, 2012		4,589,507		$	1.04		5.95
	Granted		4,135,000		$	0.5		9.6
	Exercised		-		$	-		-
	Forfeited		(750,000	)	$	1.25
	Expired				$			-
	Outstanding at December 31, 2012		7,974,507		$	0.77		6.93	$	-
	Exercisable at December 31, 2012		4,500,257		$	0.89		5.9	$	-
	Weighted average fair value of options granted during the six months ended December 31, 2012.				$	0.37
	Balance at June 30, 2013		6,337,007		$	0.75		8.25
	Granted		1,215,500		$	1.35		9.2
	Exercised		-		$	-		-
	Forfeited		-		$	-		-
	Expired		-		$	-
	Outstanding at December 31, 2013		7,552,507		$	0.86		6.48	$	692,330
	Exercisable at December 31, 2013		4,170,173		$	0.94		4.92	$	222,689
	Weighted average fair value of options granted during the six months ended December 31, 2013				$	0.69
Directors [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of Options Activity	'
	A summary of options issued to directors under the 2007 Plan and changes during the period from June 30, 2012 to December 31, 2012 and from June 30, 2013 to December 31, 2013 is as follows:
	Options Issued to Directors
		Number of			Weighted		Weighted		Aggregate
		Options			Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Life
	Balance at June 30, 2012		857,500		$	1.36		7.96
	Granted		235,000		$	0.9		10
	Exercised		-		$	-		-
	Forfeited		-		$	-		-
	Expired		-		$	-		-
	Outstanding at December 31, 2012		1,092,500		$	1.26		7.9	$	-
	Exercisable at December 31, 2012		756831		$	1.38		7.37	$	-
	Weighted average fair value of options granted during the six months ended December 31, 2012				$	0.65
	Balance at June 30, 2013		1,200,833		$	1.16		8.04
	Granted		495,000		$	1.19		10
	Exercised		(20,000	)	$	0.91		-
	Forfeited		-		$	-		-
	Expired		-		$	-		-
	Outstanding at December 31, 2013		1,675,833		$	1.12		8.11	$	6,287
	Exercisable at December 31, 2013		885,835		$	1.23		6.98	$	5,154
	Weighted average fair value of options granted during the six months ended December 31, 2013				$	0.76
Non-Employee, Non-Director Options [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of Options Activity	'
	A summary of options issued to non-employees under the 2007 Plan and changes during the six month periods from June 30, 2012 to December 31, 2012 and from June 30, 2013 to December 31, 2013 is as follows:
	Non-Employee, Non-Director Options
		Number of			Weighted		Weighted		Aggregate
		Options			Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Life
	Balance at June 30, 2012		540,000		$	1.16		3.14
	Granted		-		$	-		-
	Exercised		(100,000	)	$	0.5
	Forfeited		-		$	-		-
	Expired		-		$	-		-
	Outstanding at December 31, 2012		440,000		$	1.14		1.77	$	-
	Exercisable at December 31, 2012		440,000		$	1.14		1.77	$	-
	Weighted average fair value of options granted during the six months ended December 31, 2012					N/A
	Balance at June 30, 2013		560,000		$	1.22		5.96
	Granted		20,000		$	1.18		5
	Exercised		-		$	-		-
	Forfeited		-		$	-		-
	Expired		-		$	-		-
	Outstanding at December 31, 2013		580,000		$	1.22		5.43	$	-
	Exercisable at December 31, 2013		305,000		$	1.21		1.92	$	-
	Weighted average fair value of options granted during the six months ended December 31, 2013				$	0.96
Warrants Issued for Cash or Services [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of Warrant Activity	'
	A summary of warrants issued for cash and changes during the periods June 30, 2012 to December 31, 2012 and from June 30, 2013 to December 31, 2013 is as follows:
	Warrants issued for cash or services
		Number of			Weighted		Remaining
		Warrants			Average		Contractual
					Exercise		Life
					Price
	Balance at June 30, 2012		4,481,200		$	1.46		2.46
	Granted		50,000		$	0.63		5
	Exercised		(1,820,000	)	$	0.5		-
	Exercise rescission		-		$	-
	Forfeited		-		$	-		-
	Expired		(320,000	)	$	1.6		-
	Outstanding at December 31, 2012		2,391,200		$	1.42		1
	Exercisable at December 31, 2012		2,91,200		$	1.42		1
	Weighted average fair value of options granted during the six months ended December 31, 2012				$	0.44
	Balance at June 30, 2013		1,533,700		$	1.25		2.06
	Granted		949,412		$	1.17		5
	Exercised		(20,000	)	$	1.25		-
	Forfeited		-		$	-		-
	Expired		(325,000	)	$	1.25		-
	Outstanding at December 31, 2013		2,138,112		$	1.22		3.46
	Exercisable at December 31, 2013		2,138,112		$	1.22		3.46
	Weighted average fair value of options granted during the six months ended December 31, 2013					N/A
Warrants Issued As Settlements [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of Warrant Activity	'
	A summary of warrants issued for settlements and changes during the periods July 1, 2012 to December 31, 2012 and from July 1, 2013 to December 31, 2013 is as follows:
	Warrants Issued as Settlements
		Number of			Weighted		Remaining
		Warrants			Average		Contractual
					Exercise		Life
					Price
	Balance at June 30, 2012		344,058		$	1.05		0.92
	Granted		350,000		$	0.6		5
	Exercised		-		$	-		-
	Forfeited		-		$	-		-
	Expired		-		$	-		-
	Outstanding at December 31, 2012		694,058		$	0.84		2.58
	Exercisable at December 31, 2012		694,058		$	0.84		2.58
	Weighted average fair value of options granted during the six months ended December 31, 2012				$	0.33
	Balance at June 30, 2013		350,000		$	0.63		4.22
	Granted		-		$	-		-
	Exercised		-		$	-		-
	Forfeited		-		$	-		-
	Expired		-		$	-		-
	Outstanding at December 31, 2013		350,000		$	0.63		3.74
	Exercisable at December 31, 2013		350,000		$	0.63		3.74
	Weighted average fair value of options granted during the six months ended December 31, 2013					N/A

Organization_and_Basis_of_Pres3

Organization and Basis of Presentation (Details) (USD $)	6 Months Ended
	Dec. 31, 2013
Inventory, Gross [Abstract]	'
Inventory, Raw Materials	390,337
Inventory, Finished Goods	472,807
Stock Options [Member]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'
Shares considered antidilutive	9,808,340
Warrants [Member]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'
Shares considered antidilutive	2,488,112
Stock Options For Convertible Notes Reserved [Member]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'
Shares considered antidilutive	6,707,094

Organization_and_Basis_of_Pres4

Organization and Basis of Presentation (Schedule of Fair Value Assumptions) (Details)	6 Months Ended
	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Dividend yield	'
Estimated annual forfeitures	'
Minimum [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Risk free interest rate	0.45%
Expected term	'2 years 6 months
Volatility	90.96%
Maximum [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Risk free interest rate	2.61%
Expected term	'6 years 6 months
Volatility	91.94%

Going_Concern_Details

Going Concern (Details) (USD $)	1 Months Ended	3 Months Ended		6 Months Ended			1 Months Ended	6 Months Ended
	Aug. 30, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013	Jan. 31, 2012	Dec. 31, 2013
							Lincoln Park Capital Fund, LLC. [Member]	Lincoln Park Capital Fund, LLC. [Member]
Going Concern [Abstract]	'	'	'	'	'	'	'	'
Net cash used in operating activities	'	'	'	$2,769,198	$1,994,491	'	'	'
Loss from operations	'	1,914,197	1,509,085	3,730,330	3,027,504	'	'	'
Working capital deficit	'	4,585	'	4,585	'	'	'	'
Accumulated deficit	'	31,985,880	'	31,985,880	'	28,021,633	'	'
Stockholders' deficit	'	1,880,313	'	1,880,313	'	2,270,386	'	'
Related Party Transaction [Line Items]	'	'	'	'	'	'	'	'
Potential proceeds from sale of equity	'	'	'	'	'	'	4,900,000	3,100,000
Common stock issued	20,000	'	'	'	'	'	'	2,913,997
Number of shares callable by warrants	'	'	'	'	'	'	'	1,990,003
Proceeds from private placement	'	'	'	$730,000	'	'	$100,000	'

Convertible_and_NonConvertible1

Convertible and Non-Convertible Note Agreements (Details) (USD $)

1 Months Ended

3 Months Ended

6 Months Ended

1 Months Ended

1 Months Ended

1 Months Ended

1 Months Ended

1 Months Ended

Aug. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2013

Feb. 28, 2013

Feb. 28, 2011

Sep. 30, 2012

Feb. 28, 2011

Aug. 30, 2013

Mar. 31, 2012

Sep. 30, 2012

Sep. 30, 2012

Mar. 31, 2012

Dec. 31, 2012

Jul. 31, 2013

31-May-09

29-May-09

Aug. 30, 2013

Feb. 28, 2013

Aug. 31, 2012

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Convertible OID Note [Member]

Convertible Note [Member]

Convertible Note [Member]

Reduction In Principal Amount Of Line Of Credit [Member]

Third Party [Member]

Third Party [Member]

Third Party [Member]

Director [Member]

Director [Member]

Principal Stockholder [Member]

Principal Stockholder [Member]

Principal Stockholder [Member]

Principal Stockholder [Member]

Investors [Member]

Investors [Member]

Investors [Member]

Chief Executive Officer [Member]

President [Member]

Chief Financial Officer [Member]

Convertible OID Note [Member]

Convertible OID Note [Member]

Convertible OID Note [Member]

Convertible OID Note [Member]

Convertible OID Note [Member]

Convertible OID Note [Member]

Convertible Note [Member]

Line of Credit [Member]

Line of Credit [Member]

Convertible OID Note [Member]

Convertible OID Note [Member]

Convertible OID Note [Member]

Shareholder Advances [Member]

Shareholder Advances [Member]

Shareholder Advances [Member]

Debt Conversion [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from issuance of debt

'

'

'

'

'

'

$250,000

'

'

'

'

$105,000

'

'

$75,000

$250,000

'

'

'

'

'

$75,000

'

'

'

Debt issued

'

'

'

'

'

'

1,997,483

1,497,483

'

'

'

107,625

120,540

86,100

76,875

275,000

1,000,000

'

'

'

86,100

76,875

10,000

29,380

50,000

Term

'

'

'

'

'

'

'

'5 years

'

'

'

'9 months

'

'1 year

'6 months

'1 year

'

'

'

'

'1 year

'6 months

'

'

'

Debt, interest rate

'

'

'

'

'

'

7.50%

5.00%

'

'

'

5.00%

12.00%

12.00%

5.00%

10.00%

7.50%

'

5.00%

'

'

5.00%

0.70%

5.00%

5.00%

Convertible note, conversion price

'

'

'

'

'

'

$0.35

$1.12

'

'

'

$0.50

$0.50

$0.50

$0.50

$0.35

$1

'

'

'

$0.35

$0.50

'

'

'

Unamortized beneficial conversion feature

'

'

'

'

'

'

114,142

'

'

'

'

84,562

'

'

63,038

23,571

601,949

'

'

'

4,920

1,875

'

'

'

Unamortized discount on notes payable

'

'

'

'

'

'

'

'

'

'

'

'

35,138

24,971

'

25,000

'

'

'

'

9,225

55,350

'

'

'

Amortization of beneficial conversion feature of convertible notes

'

'

'

'

'

'

35,703

'

'

'

'

'

'

'

'

'

86,632

'

'

'

'

'

'

'

'

Accrued interest

'

'

'

'

'

'

73,579

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest expense

'

127,392

97,226

239,764

314,054

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible note payable

'

'

'

'

'

79,261

275,000

'

'

'

86,100

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayment of convertible note with third party

'

'

'

115,822

'

'

'

'

'

'

85,822

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of credit, borrowing capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,500,000

'

'

'

'

'

'

Line of credit, commencement date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20-Jul-09

'

'

'

'

'

'

'

Shares issued from conversion of convertible debt

'

'

'

'

'

'

'

'

'

'

8,880

'

'

'

'

'

'

'

'

234,663

205,000

'

'

'

'

Number of shares callable by warrants

'

'

'

'

'

'

'

300,000

'

1,000,000

'

'

'

'

'

'

500,000

'

'

'

'

'

'

'

'

Exercise price of shares called by warrants

1.25

'

'

'

'

'

'

1.75

0.5

1.25

'

'

'

'

'

'

1.3

'

'

'

'

'

'

'

'

Debt conversion, cash payment amount

'

'

'

'

'

'

'

'

150,000

'

30,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt conversion, amount

'

'

'

'

'

'

'

'

'

1,000,000

'

'

'

'

'

'

'

'

'

'

102,500

'

'

'

'

Value of convertible original issue discount note

'

'

'

'

'

'

'

'

'

'

34,440

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss on extinguishment of debt

'

'

'

'

'

'

21,311

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss on conversion of interest

'

'

'

'

'

'

4,204

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock options expense

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15,067

Granted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

150,000

Granted shares, exercise price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.95

Common shares issued

20,000

'

'

'

'

'

210,226

'

'

892,857

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Granted shares, reduced exercise price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.6

Fair value of options

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$311,949

'

'

'

'

'

'

'

'

Volatility rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

91.46%

'

'

'

'

'

'

'

'

Expected term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

Discount rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.40%

'

'

'

'

'

'

'

'

Stockholders_Equity_Preferred_

Stockholders' Equity (Preferred Stock) (Details) (USD $)	Dec. 31, 2013	Jun. 30, 2013
Stockholders' Equity [Abstract]	'	'
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, par value per share	$0.00	$0.00

Stockholders_Equity_Common_Sto

Stockholders' Equity (Common Stock) (Details) (USD $)

1 Months Ended

2 Months Ended

6 Months Ended

1 Months Ended

6 Months Ended

1 Months Ended

1 Months Ended

6 Months Ended

1 Months Ended

6 Months Ended

Aug. 30, 2013

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Jan. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Jul. 31, 2013

Sep. 30, 2012

Oct. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Oct. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Lincoln Park Capital Fund, LLC. [Member]

Lincoln Park Capital Fund, LLC. [Member]

Lincoln Park Capital Fund, LLC. [Member]

Director [Member]

Director [Member]

Director [Member]

Investors [Member]

COO and principal shareholder [Member]

COO and principal shareholder [Member]

Accredited Investors [Member]

Accredited Investors [Member]

Accredited Investors [Member]

Common Stock Purchase Agreement [Member]

Private Placement [Member]

Private Placement [Member]

Common Stock Purchase Agreement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Minimum [Member]

Maximum [Member]

Stockholders Equity Note [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from exercise of stock options

'

'

$18,200

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issued

20,000

'

'

'

'

2,913,997

577,428

20,000

'

400,000

263,204

829,546

200,000

357,647

'

'

Proceeds from issuance of common stock

'

'

775,000

128,000

'

'

'

18,200

'

'

'

'

'

'

'

'

Number of accredited investors

'

'

'

'

'

'

'

'

'

'

5

'

'

4

'

'

Number of shares callable by warrants

'

'

'

'

'

1,990,003

'

'

350,000

200,000

'

'

100,000

149,412

'

'

Proceeds from private placement

'

'

730,000

'

100,000

'

570,000

'

'

300,000

225,000

550,000

150,000

280,000

'

'

Proceeds from exercise of warrants

25,000

25,000

25,000

910,000

'

'

'

'

'

'

'

'

'

'

'

'

Exercise price of shares called by warrants

1.25

'

'

'

'

'

'

'

0.63

'

'

'

1

'

1

1.25

Exercise price

'

'

'

'

'

'

'

$0.91

'

'

'

'

'

'

'

'

Granted shares, exercise price

'

'

'

'

'

'

'

'

'

$1

'

'

'

'

'

'

Loss on warrant repricing

'

'

'

$70,491

'

'

'

'

'

'

'

'

'

'

'

'

Stockholders_Equity_Options_to

Stockholders' Equity (Options to Purchase Common Stock) (Details) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share-based compensation expense	$1,235,650	$990,559
Employee Options and Stock Appreciation Rights [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Share-based compensation expense	1,235,650	'
Remaining shares vesting period	'3 years	'
Share-based compensaion expense not yet recognized	$1,659,670	'

Stockholders_Equity_Schedule_o

Stockholders' Equity (Schedule of Stock Options Activity) (Details) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Employee Options and Stock Appreciation Rights [Member]	'	'
Number of Options	'	'
Balance at beginning of period	6,337,007	4,589,507
Granted	1,215,500	4,135,000
Exercised	'	'
Forfeited	'	-750,000
Expired	'	'
Outstanding at end of period	7,552,507	7,974,507
Exercisable at end of period	4,170,173	4,500,257
Weighted Average Exercise Price	'	'
Balance at beginning of period	$0.75	$1.04
Granted	$1.35	$0.50
Exercised	'	'
Forfeited	'	$1.25
Expired	'	'
Outstanding at end of period	$0.86	$0.77
Exercisable at end of period	$0.94	$0.89
Options granted, grant price	$0.69	$0.37
Weighted Average Remaining Contractual Life	'	'
Beginning balance	'8 years 3 months	'5 years 11 months 12 days
Granted	'9 years 2 months 12 days	'9 years 7 months 6 days
Exercised	'	'
Forfeited	'	'
Expired	'6 years 5 months 5 days	'6 years 11 months 5 days
Outstanding at end of period	'6 years 5 months 23 days	'5 years 10 months 24 days
Exercisable at end of period	'4 years 11 months 1 day	'
Aggregate Intrinsic Value	'	'
Outstanding at end of period	$692,330	'
Exercisable at end of period	222,689	'
Directors [Member]	'	'
Number of Options	'	'
Balance at beginning of period	1,200,833	857,500
Granted	495,000	235,000
Exercised	-20,000	'
Forfeited	'	'
Expired	'	'
Outstanding at end of period	1,675,833	1,092,500
Exercisable at end of period	885,835	756,831
Weighted Average Exercise Price	'	'
Balance at beginning of period	$1.16	$1.36
Granted	$1.19	$0.90
Exercised	$0.91	'
Forfeited	'	'
Expired	'	'
Outstanding at end of period	$1.12	$1.26
Exercisable at end of period	$1.23	$1.38
Options granted, grant price	$0.76	$0.65
Weighted Average Remaining Contractual Life	'	'
Beginning balance	'8 years 4 months 24 days	'7 years 11 months 16 days
Granted	'10 years	'10 years
Exercised	'	'
Forfeited	'	'
Expired	'	'
Outstanding at end of period	'8 years 1 month 10 days	'7 years 10 months 24 days
Exercisable at end of period	'6 years 11 months 23 days	'7 years 4 months 13 days
Aggregate Intrinsic Value	'	'
Outstanding at end of period	6,287	'
Exercisable at end of period	5,154	'
Non Employee Non Director Options [Member]	'	'
Number of Options	'	'
Balance at beginning of period	560,000	540,000
Granted	20,000	'
Exercised	'	-100,000
Forfeited	'	'
Expired	'	'
Outstanding at end of period	580,000	440,000
Exercisable at end of period	305,000	440,000
Weighted Average Exercise Price	'	'
Balance at beginning of period	$1.22	$1.16
Granted	$1.18	'
Exercised	'	$0.50
Forfeited	'	'
Expired	'	'
Outstanding at end of period	$1.22	$1.14
Exercisable at end of period	$1.21	$1.14
Options granted, grant price	$0.96	'
Weighted Average Remaining Contractual Life	'	'
Beginning balance	'5 years 11 months 16 days	'3 years 1 month 21 days
Granted	'5 years	'
Exercised	'	'
Forfeited	'	'
Expired	'	'
Outstanding at end of period	'5 years 5 months 5 days	'1 year 9 months 7 days
Exercisable at end of period	'1 year 11 months 1 day	'1 year 9 months 7 days
Aggregate Intrinsic Value	'	'
Outstanding at end of period	'	'
Exercisable at end of period	'	'

Stockholders_Equity_Narrative_

Stockholders' Equity (Narrative) (Options) (Details) (USD $)

6 Months Ended

1 Months Ended

6 Months Ended

1 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Jul. 31, 2013

Sep. 30, 2012

Jul. 31, 2013

Oct. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Jul. 31, 2013

Sep. 30, 2012

Jul. 31, 2013

Sep. 30, 2012

Oct. 31, 2013

Sep. 30, 2013

Jul. 31, 2013

Dec. 31, 2012

Jul. 31, 2013

Jul. 31, 2012

Sep. 30, 2012

Jul. 31, 2013

Jul. 31, 2013

Jul. 31, 2013

Dec. 31, 2013

Jul. 31, 2013

Nov. 30, 2012

Aug. 30, 2013

Father of CEO and CTO [Member]

Father of CEO and CTO [Member]

Directors [Member]

Non-Employee, Non-Director Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Appreciation Rights (SARs) [Member]

Stock Appreciation Rights (SARs) [Member]

Father of CEO and CTO [Member]

Father of CEO and CTO [Member]

CEO, CFO and CTO [Member]

Non-executive Employees [Member]

Directors [Member]

Directors [Member]

Directors [Member]

Directors [Member]

Director [Member]

Director [Member]

Non-Employee, Non-Director Options [Member]

New Employee [Member]

New Employee [Member]

New Employee [Member]

Employees [Member]

Employees [Member]

CEO, CFO and CTO [Member]

New Employee [Member]

Minimum [Member]

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

400,000

'

'

Granted

'

'

25,000

70,000

'

20,000

1,215,500

4,135,000

25,000

70,000

250,000

265,000

60,000

15,000

370,000

5,000

50,000

230,000

100,000

100,000

'

'

90,500

100,000

800,000

150,000

Term

'

'

'

'

'

'5 years

'

'

'10 years

'

'10 years

'5 years

'

'

'10 years

'

'10 years

'10 years

'

'5 years

'

'

'5 years

'

'10 years

'

Terms of Award

'

'

'

'

'

'

'

'

'

'

'vest 50% upon the market value of the Company's common stock trading at or greater than $2.00 per share for any 10 day period out of a 30 day trading period and the other 50% vesting upon the market value of the Company's common stock trading at or greater than $3.00 per share for any 10 day period out of a 30 day trading period.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Granted shares, exercise price

'

'

'

'

'

$1.18

$1.35

$0.50

$1.30

$0.63

$1.30

$0.60

$1.17

$1.01

$1.15

$0.36

$1.30

$0.91

$1.25

'

$1.25

$1.75

$0.72

'

$0.45

$1.52

Vesting period

'

'

'

'

'

'

'

'

'3 years

'

'

'3 years

'

'

'

'3 years

'

'

'

'3 years

'

'

'

'

'

'

Remaining vesting period, shares vested

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

75

'

'

'

'

'

'

Percentage of shares immediately vested

'

'

'

'

'

'

'

'

'

'

'

25.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Immediately vested shares

'

'

'

'

'

'

'

'

'

35,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000

50,000

Volatility

'

'

'

'

'

91.91%

'

'

91.72%

90.09%

93.11%

89.93%

91.94%

91.60%

93.11%

89.86%

93.11%

91.04%

'

91.61%

'

'

90.96%

91.72%

89.67%

91.91%

Expected term, simplified method

'

'

'

'

'

'5

'

'

'1.5

'4

'6.5

'4

'6.5

'5.0

'5.5

'6.5

'6.5

'5.5

'

'4.0

'

'

'2.5

'2.5

'6.5

'4.0

Discount rate

'

'

'

'

'

1.38%

'

'

2.61%

0.53%

2.62%

0.53%

1.89%

1.62%

1.52%

0.90%

2.67%

0.82%

'

1.14%

'

'

0.55%

0.45%

0.93%

1.97%

Fair value of options

'

'

'

'

'

$16,670

'

'

$25,272

$28,358

'

$101,029

$54,285

$10,702

'

$1,360

'

'

'

$80,413

'

'

$34,610

$69,452

$1,086,560

$176,413

Percentage expensed immediately

'

'

'

'

'

'

'

'

'

'

'

25.00%

'

'

'

'

'

'

'

25.00%

'

'

'

'

25.00%

'

Cash received from stock options exercised

18,200

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50,000

'

'

'

'

'

'

'

Exercise price

'

'

'

'

$0.91

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.50

'

'

'

'

'

'

'

Exercised options

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

'

'

'

'

Options exercisable

'

'

'

'

'

'

4,170,173

4,500,257

'

'

'

'

'

'

'

'

'

'

'

50,000

'

'

'

'

'

'

Options exercisable, exercise price

'

'

'

'

'

'

$0.94

$0.89

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Remaining vesting period, percentage of shares vested

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

75.00%

'

'

'

'

'

'

Fair market value of stock, per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.30

'

'

Cancelled options

'

'

'

'

'

'

'

750,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cancelled, exercise price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$250,000

'

Options expense

'

'

'

'

'

'

'

'

'

'

63,180

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Vested shares upon generating $3,000,000 in revenue in any 12-month period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000

33,334

Vested shares upon generating $5,000,000 in revenue in any 12-month period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000

33,333

Vested shares upon generating $6,000,000 in revenue in any 12-month period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000

33,333

Loss on warrant repricing

'

$70,491

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$391

'

'

'

'

'

'

'

Stockholders_Equity_Schedule_o1

Stockholders' Equity (Schedule of Warrant Activity) (Details) (USD $)	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Warrants Issued for Cash or Services [Member]	'	'
Number of Warrants	'	'
Balance at the beginning of period	1,533,700	4,481,200
Granted	949,412	50,000
Exercised	-20,000	-1,820,000
Forfeitured	'	'
Expired	-325,000	-320,000
Outstanding at the end of period	2,138,112	2,391,200
Exercisable at end of period	2,138,112	291,200
Weighted Average Exercise Price	'	'
Balance at beginning of period	$1.25	$1.46
Granted	$1.17	$0.63
Exercised	$1.25	$0.50
Expired	$1.25	$1.60
Exercise rescission	'	'
Outstanding at end of period	$1.22	$1.42
Exercisable at end of period	$1.22	$1.42
Fair value of warrants granted	'	$0.44
Remaining Contractual Life	'	'
Beginning balance	'2 years 22 days	'2 years 5 months 16 days
Granted	'5 years	'5 years
Outstanding at end of period	'3 years 5 months 16 days	'1 year
Exercisable at end of period	'3 years 5 months 16 days	'1 year
Warrants Issued As Settlements [Member]	'	'
Number of Warrants	'	'
Balance at the beginning of period	350,000	344,058
Granted	'	350,000
Exercised	'	'
Forfeitured	'	'
Expired	'	'
Outstanding at the end of period	350,000	694,058
Exercisable at end of period	350,000	694,058
Weighted Average Exercise Price	'	'
Balance at beginning of period	$0.63	$1.05
Granted	'	$0.60
Outstanding at end of period	$0.63	$0.84
Exercisable at end of period	$0.63	$0.84
Fair value of warrants granted	'	$0.33
Remaining Contractual Life	'	'
Beginning balance	'4 years 2 months 19 days	'11 months 1 day
Granted	'	'5 years
Outstanding at end of period	'3 years 8 months 27 days	'2 years 6 months 29 days
Exercisable at end of period	'3 years 8 months 27 days	'2 years 6 months 29 days

Stockholders_Equity_Narrative_1

Stockholders' Equity (Narrative) (Warrant) (Details) (USD $)

1 Months Ended

2 Months Ended

6 Months Ended

1 Months Ended

1 Months Ended

Aug. 30, 2013

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2012

Sep. 30, 2012

Oct. 31, 2013

Jul. 31, 2013

Sep. 30, 2012

Jul. 31, 2013

Sep. 30, 2012

Jul. 31, 2013

Minimum [Member]

Maximum [Member]

Director [Member]

Investor Relations Firm [Member]

Private Placement Five Year Warrants [Member]

Private Placement Five Year Warrants [Member]

Five Year Warrants [Member]

Five Year Warrants [Member]

Five Year Warrants [Member]

Five Year Warrants [Member]

Director [Member]

Investor [Member]

Director [Member]

Director [Member]

Investor Relations Firm [Member]

Principal Stockholder [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares callable by warrants

'

'

'

'

'

'

350,000

50,000

120,000

29,412

'

500,000

'

'

Warrant exercise price

1.25

'

'

'

'

'

0.63

0.63

1

1.3

'

1.3

'

'

Fair value

'

'

'

'

'

'

'

'

'

'

$115,883

'

$21,787

'

Volatility rate

'

'

'

'

90.96%

91.94%

'

'

'

'

90.09%

'

90.09%

'

Expected term

'

'

'

'

'2 years 6 months

'6 years 6 months

'

'

'

'

'

'

'5 years

'

Expected term, simplified method

'

'

'

'

'

'

'

'

'

'

'2.5

'

'

'

Discount rate

'

'

'

'

'

'

'

'

'

'

0.32%

'

0.70%

'

Proceeds from exercise of warrants

25,000

25,000

25,000

910,000

'

'

'

'

'

'

'

'

'

'

Convertible note, amount

'

'

'

'

'

'

'

'

'

'

'

'

'

1

Warrants exercised, shares issued

20,000

'

'

1,820,000

'

'

'

'

'

'

'

'

'

'

Cost of repricing warrants to induce exercise

'

'

'

$70,491

'

'

'

'

'

'

'

'

'

'

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)

1 Months Ended

6 Months Ended

1 Months Ended

1 Months Ended

1 Months Ended

12 Months Ended

Nov. 30, 2012

Dec. 31, 2013

Dec. 31, 2012

Nov. 30, 2012

Nov. 30, 2012

Nov. 14, 2012

Nov. 30, 2012

Nov. 30, 2012

Dec. 31, 2012

Nov. 30, 2012

Jun. 30, 2012

Jan. 31, 2013

Jul. 31, 2012

Jul. 31, 2012

Jul. 31, 2012

Jan. 31, 2013

Jul. 31, 2012

Dec. 31, 2012

Chief Executive Officer, Chief Technology Officer, Chief Financial Officer and Former President [Member]

Executive Chairman [Member]

Executive Chairman [Member]

Stock Appreciation Rights (SARs) [Member]

Restricted Stock Units (RSUs) [Member]

Loss Contingency Invasion Of Privacy And Misrepresentation [Member]

Loss Contingency Invasion Of Privacy And Misrepresentation [Member]

Loss Contingency Invasion Of Privacy And Misrepresentation [Member]

Loss Contingency Breach Of Agreement [Member]

Loss Contingency Breach Of Agreement [Member]

Loss Contingency Trespass Claim [Member]

Loss Contingency Civil Theft [Member]

Loss Contingency Civil Theft Law Enforced Settlement [Member]

Loss Contingency Civil Theft Law Enforced Settlement [Member]

Loss Contingency Civil Theft Law Enforced Settlement [Member]

Chief Executive Officer, Chief Technology Officer, Chief Financial Officer and Former President [Member]

Executive Chairman [Member]

Commitments and Contingencies [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Rent expense

'

$84,009

$53,479

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss Contingencies [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Litigation accrual

'

'

'

'

'

'

'

'

'

'

1,646,000

'

'

'

'

'

'

'

Litigation, provision

'

'

'

'

'

'

'

'

200,000

'

'

500,000

841,000

5,000

200,000

'

600,000

941,000

Damages paid to plaintiff by insurance carrier

'

'

'

'

'

'

'

'

'

200,000

'

'

'

'

'

'

'

'

Portion of litigation expense that was dismissed

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000

'

'

Amount paid by insurance

200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Immediately vested shares

'

'

'

'

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

Vested shares upon generating $3,000,000 in revenue in any 12-month period

'

'

'

'

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

Vested shares upon generating $6,000,000 in revenue in any 12-month period

'

'

'

'

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

Vested shares upon generating $5,000,000 in revenue in any 12-month period

'

'

'

'

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

Increase in salary upon the Company generating $3,000,000 in revenue in any 12-month period

'

'

'

170,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Increase in salary upon the Company generating $5,000,000 in any 12-month period

'

'

'

190,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Increase in salary upon Company generating $6,000,000 in any 12-month period

'

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Granted

'

'

'

'

800,000

'

800,000

800,000

'

'

'

'

'

'

'

'

'

'

Cancelled options

'

'

'

250,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Monthly car allowance

600

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Annual base salary per executive

'

'

'

'

'

$200,000

'

'

'

'

'

'

'

'

'

'

'

'

Granted shares, exercise price

'

'

'

'

'

'

$0.45

'

'

'

'

'

'

'

'

'

'

'

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	6 Months Ended			1 Months Ended					1 Months Ended
	Dec. 31, 2013	Jun. 30, 2013	Sep. 30, 2013	Jul. 31, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012	Feb. 28, 2013	Feb. 28, 2013	Feb. 28, 2013
			CEO's Wife [Member]	CEO and CTO's Father [Member]	CEO and CTO's Father [Member]	CEO and CTO's Father [Member]	CEO and CTO's Mother [Member]	Directors [Member]	President [Member]	President [Member]	President [Member]
										Minimum [Member]	Maximum [Member]
Related Party Transaction [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Weekly salary amount	'	'	$1,200	'	'	$2,123	$600	'	'	'	'
Severance expense	168,920	'	'	'	'	'	'	'	150,000	'	'
Options granted, grant price	'	'	'	'	'	'	'	'	$0.39	$0.45	$1.22
Granted	'	'	'	25,000	70,000	'	'	'	112,500	'	'
Common shares cancelled	'	'	'	'	'	'	'	'	2,125,000	'	'
Accrual for severance agreement	$17,596	$102,056	'	'	'	'	'	'	'	'	'
Number of shares callable by warrants	'	'	'	'	'	'	'	350,000	'	'	'

Concentrations_Details

Concentrations (Details) (USD $)	6 Months Ended
	Dec. 31, 2013
Concentration Risk [Line Items]	'
Cash balance not insured by the FDIC	'
Total EMFIDS parts, raw material and packaging purchases made during the period	471,000
Accounts Receivable [Member]	'
Concentration Risk [Line Items]	'
Number of customers in concentration	3
Accounts Receivable [Member] | Customer One Concentration Risk [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	48.40%
Accounts Receivable [Member] | Customer Two Concentration Risk [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	17.70%
Accounts Receivable [Member] | Customer Three Concentration Risk [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	14.00%
Sales Revenue [Member]	'
Concentration Risk [Line Items]	'
Number of products in concentration	2
Sales Revenue [Member] | Customer One Concentration Risk [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	76.90%
Sales Revenue [Member] | Fire Ice [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	89.03%
Sales Revenue [Member] | Soil 2 O [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	11.00%
Sales Revenue [Member] | Paid For Research And Development [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	1.93%
Sales Revenue [Member] | Fire Ice EMFIDS Product [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	80.20%
Sales Revenue [Member] | Fire Ice Products [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	16.60%
Sales Revenue [Member] | Fire Ice Home Defence Product [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	1.30%
Sales Revenue [Member] | Soil 2 O Traditional Sales [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	1.30%
Sales Revenue [Member] | Soil 2 O Dust Control Products [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	98.70%
Inventory purchases [Member]	'
Concentration Risk [Line Items]	'
Number of customers in concentration	4
Inventory purchases [Member] | Vendor One Concentration Risk [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	36.10%
Inventory purchases [Member] | Vendor Two Concentration Risk [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	17.10%
Inventory purchases [Member] | Vendor Three Concentration Risk [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	13.60%
Inventory purchases [Member] | Vendor Four Concentration Risk [Member]	'
Concentration Risk [Line Items]	'
Concentration risk, percentage	11.30%

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	1 Months Ended	6 Months Ended			6 Months Ended		1 Months Ended
	Aug. 30, 2013	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2013	Dec. 31, 2013	Jan. 31, 2014	Jan. 31, 2014
					Accredited Investors [Member]	Subsequent Event [Member]	Subsequent Event [Member]
					Private Placement [Member]		Accredited Investors [Member]
							Private Placement [Member]
Subsequent Event [Line Items]	'	'	'	'	'	'	'
Common Stock, Shares Authorized	'	50,000,000	'	50,000,000	'	100,000,000	'
Common stock issued	20,000	'	'	'	357,647	'	1,417,056
Proceeds from issuance of common stock	'	$775,000	$128,000	'	'	'	$832,875
Number of accredited investors	'	'	'	'	4	'	7